Insulin degludec/insulin aspart administered once daily at any meal, with insulin aspart at other meals versus a standard basal-bolus regimen in patients with type 1 diabetes: a 26-week, phase 3, randomized, open-label, treat-to-target trial (Q36334638)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Insulin degludec/insulin aspart administered once daily at any meal, with insulin aspart at other meals versus a standard basal-bolus regimen in patients with type 1 diabetes: a 26-week, phase 3, randomized, open-label, treat-to-target trial |
scientific article |
Statements
1 reference
Insulin degludec/insulin aspart administered once daily at any meal, with insulin aspart at other meals versus a standard basal-bolus regimen in patients with type 1 diabetes: a 26-week, phase 3, randomized, open-label, treat-to-target trial (English)
1 reference
Edward Franek
1 reference
Irl B Hirsch
1 reference
Bruce Bode
1 reference
Jean-Pierre Courreges
1 reference
Patrik Dykiel
1 reference
Kjeld Hermansen
1 reference
Allen King
1 reference
Henriette Mersebach
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference